Log in
EA

EVENTIDE ASSET MANAGEMENT, LLC

EVENTIDE ASSET MANAGEMENT, LLC · Investor
1Y performance ⓘ
+47%
AUM (13F)
$6.0B
# of Holdings
278
3Y performance ⓘ
+59%
vs S&P 500 ⓘ
−12%
Updated
Mar 31

EVENTIDE ASSET MANAGEMENT, LLC's EVENTIDE ASSET MANAGEMENT, LLC holds 278 U.S.-equity positions worth $6.0B (SEC 13F, Q1 2026). Top positions: Guardant Health, Inc. Common Stock 3.6%, Trane Technologies plc 2.8%, Lam Research Corp 2.4%. 13F-replication return is +59% over 3 years (-12 pts vs the S&P 500) — a replicated, non-audited figure.

Holdings

Stock% of portfolio SharesValue Latest activityAvg buy price Current priceDate
GH Guardant Health, Inc. Common Stock 3.6% 2.4M $218M ▼ 5.9% (−149K) $23.44 $128.83 (+450%) 2026-03-31
TT Trane Technologies plc 2.8% 407K $169M ▲ 0.8% (+3K) $183.98 $491.59 (+167%) 2026-03-31
LRCX Lam Research Corp 2.4% 688K $147M ▲ 2.9% (+19K) $72.23 $409.54 (+467%) 2026-03-31
MIRM Mirum Pharmaceuticals, Inc. Common Stock 2.1% 1.4M $130M ▼ 33% (−685K) $24.02 $107.77 (+349%) 2026-03-31
TRGP Targa Resources Corp. 2.1% 502K $126M ▲ 4.5% (+22K) $72.95 $264.51 (+263%) 2026-03-31
XMTR Xometry, Inc. Class A Common Stock 2.0% 3.0M $121M ▲ 0.8% (+24K) $14.97 $91.56 (+512%) 2026-03-31
GEV GE Vernova Inc. 1.9% 133K $116M ▼ 29% (−54K) $328.94 $1,127.59 (+243%) 2026-03-31
ODFL Old Dominion Freight Line 1.9% 592K $115M ▼ 3.1% (−19K) $340.84 $219.52 (−36%) 2026-03-31
SRRK Scholar Rock Holding Corporation Common Stock 1.8% 2.2M $108M ▼ 9.6% (−234K) $18.80 $49.19 (+162%) 2026-03-31
ARGX Argenx Se 1.5% 126K $92M ▲ 3.7% (+4K) $372.58 $903.75 (+143%) 2026-03-31
ASML Asml Hldg Nv 1.5% 68K $90M ▲ 1.9% (+1K) $680.71 $1,929.25 (+183%) 2026-03-31
IRTC iRhythm Holdings, Inc. Common Stock 1.5% 761K $90M ▲ 9.9% (+68K) $124.03 $104.69 (−16%) 2026-03-31
INSM Insmed, Inc. 1.5% 546K $89M ▲ 13% (+63K) $17.05 $98.61 (+478%) 2026-03-31
AXSM Axsome Therapeutics, Inc 1.4% 520K $88M ▼ 9.0% (−52K) $69.89 $247.85 (+255%) 2026-03-31
PCVX Vaxcyte, Inc. Common Stock 1.3% 1.4M $80M ▲ 50% (+457K) $50.98 $52.11 (+2%) 2026-03-31
ETR Entergy Corporation 1.3% 683K $77M ▲ 1.5% (+10K) $75.82 $112.20 (+48%) 2026-03-31
VST Vistra Corp. 1.2% 493K $74M ▲ 1.0% (+5K) $33.18 $167.26 (+404%) 2026-03-31
URI United Rentals, Inc. 1.2% 98K $71M ▲ 1.9% (+2K) $626.71 $1,092.68 (+74%) 2026-03-31
LBRT Liberty Energy Inc. 1.1% 2.4M $69M ▲ 22% (+433K) $18.47 $27.85 (+51%) 2026-03-31
TOST Toast, Inc. 1.1% 2.5M $66M $22.57 $24.26 (+7%) 2026-03-31
MTD Mettler-Toledo International 1.1% 51K $64M ▲ 1.0% (+493) $1,530.21 $1,164.07 (−24%) 2026-03-31
MPWR Monolithic Power Systems, Inc. 1.1% 58K $63M ▼ 15% (−10K) $500.54 $1,537.88 (+207%) 2026-03-31
RPRX Royalty Pharma plc Class A Ordinary Shares 1.0% 1.3M $63M ▲ 1.2% (+16K) $36.03 $53.57 (+49%) 2026-03-31
NVT nVent Electric plc Ordinary Shares 1.0% 524K $62M ▲ 1.7% (+9K) $42.94 $184.34 (+329%) 2026-03-31
WMB Williams Companies Inc. 1.0% 832K $61M ▲ 4.9% (+39K) $29.86 $74.95 (+151%) 2026-03-31
NDAQ Nasdaq, Inc. Common Stock 1.0% 712K $60M ▲ 0.7% (+5K) $54.67 $82.61 (+51%) 2026-03-31
GNRC GENERAC HOLDINGS INC 1.0% 307K $60M ▲ 227% (+213K) $108.01 $295.54 (+174%) 2026-03-31
BBNX Beta Bionics, Inc. Common Stock 1.0% 5.9M $60M ▲ 19% (+951K) $12.24 $13.70 (+12%) 2026-03-31
DHI D.R. Horton Inc. 1.0% 431K $59M ▲ 0.9% (+4K) $97.69 $155.94 (+60%) 2026-03-31
KLAC KLA Corporation Common Stock 1.0% 40K $58M ▼ 12% (−6K) $399.17 $269.16 (−33%) 2026-03-31
BLTE Belite Bio Inc 0.9% 358K $57M ▼ 6.6% (−25K) $74.00 $147.07 (+99%) 2026-03-31
LSCC Lattice Semiconductor Corp 0.9% 611K $57M ▼ 1.6% (−10K) $95.50 $155.27 (+63%) 2026-03-31
PLD PROLOGIS, INC. 0.9% 427K $56M ▲ 1.5% (+6K) $124.77 $143.83 (+15%) 2026-03-31
TMDX TransMedics Group, Inc. Common Stock 0.9% 549K $55M $83.98 $75.51 (−10%) 2026-03-31
DTM DT Midstream, Inc. 0.9% 402K $54M ▲ 1.8% (+7K) $99.45 $145.04 (+46%) 2026-03-31
NI NiSource Inc. 0.9% 1.1M $53M ▲ 0.9% (+10K) $36.76 $47.63 (+30%) 2026-03-31
KYMR Kymera Therapeutics, Inc. Common Stock 0.9% 627K $52M $40.20 $99.45 (+147%) 2026-03-31
RBA RB Global, Inc. 0.8% 528K $51M $90.21 $108.63 (+20%) 2026-03-31
WCN Waste Connections, Inc. 0.8% 310K $50M $139.07 $153.43 (+10%) 2026-03-31
ORLY O'Reilly Automotive, Inc. 0.8% 540K $50M $848.98 $85.63 (−90%) 2026-03-31
PWR Quanta Services, Inc. 0.8% 89K $49M ▲ 0.5% (+454) $254.09 $740.14 (+191%) 2026-03-31
COLL Collegium Pharmaceutical, Inc. Common Stock 0.8% 1.4M $47M ▼ 24% (−452K) $23.99 $33.45 (+39%) 2026-03-31
APGE Apogee Therapeutics, Inc. Common Stock 0.8% 557K $47M ▲ 28% (+121K) $75.48 $132.55 (+76%) 2026-03-31
VMC Vulcan Materials Company(Holding Company) 0.8% 170K $46M $233.30 $304.39 (+30%) 2026-03-31
NVDA NVIDIA CORP 0.7% 259K $45M ▲ 8.4% (+20K) $277.77 $208.65 (−25%) 2026-03-31
EGP EastGroup Properties Inc. 0.7% 236K $44M $165.32 $203.22 (+23%) 2026-03-31
IONS Ionis Pharmaceuticals, Inc. Common Stock 0.7% 575K $43M $35.74 $75.89 (+112%) 2026-03-31
STE STERIS plc 0.7% 195K $43M ▲ 2.2% (+4K) $191.28 $200.40 (+5%) 2026-03-31
PANW Palo Alto Networks, Inc. Common Stock 0.7% 252K $40M ▲ 73% (+106K) $199.74 $286.40 (+43%) 2026-03-31
LOW Lowe's Companies Inc. 0.7% 171K $40M $199.97 $214.40 (+7%) 2026-03-31

Showing top 50 of 278 holdings by value.

Related
GH stockTT stockLRCX stockMIRM stockAll hedge funds
FAQ

What are EVENTIDE ASSET MANAGEMENT, LLC's largest holdings?

As of the latest 13F: Guardant Health, Inc. Common Stock 3.6%, Trane Technologies plc 2.8%, Lam Research Corp 2.4%, Mirum Pharmaceuticals, Inc. Common Stock 2.1%, Targa Resources Corp. 2.1%.

How big is EVENTIDE ASSET MANAGEMENT, LLC's 13F portfolio?

$6.0B across 278 disclosed U.S.-equity positions.

What is EVENTIDE ASSET MANAGEMENT, LLC's 3-year performance?

+59% (13F-replication, price return), -12 pts vs the S&P 500. Not an audited fund return.

Where does this data come from?

U.S. SEC Form 13F-HR institutional holdings filings.

Sourced from SEC Form 13F-HR filings · Not investment advice
SEC EDGAR 13F
Data as of 2026-03-31 · Methodology
13F-replication (price return, filing-date based) — not an audited fund return.
Published by WealthFile · Not investment advice.

Latest activity = change vs. the prior 13F. Avg buy price = est. entry over the trailing 3 years (gain = vs. latest price). Returns are 13F-replication, not audited fund returns. Sourced from SEC 13F filings.